NEC Baby Formula Lawsuit 2026: The $60 Million Verdict, Who Qualifies & How to File

Premature infants fed cow's-milk-based formulas like Similac or Enfamil in a NICU and diagnosed with necrotizing enterocolitis may have a claim if the manufacturer failed to warn of the NEC risk. Juries have decided for families in some trials and for the manufacturers in others; federal cases are coordinated in MDL 3026 in Chicago.

Key facts

  • March 2024: a St. Clair County, Illinois jury awarded $60 million to Jasmine Watson, finding Mead Johnson's Enfamil caused her premature son's fatal NEC.
  • July 2024: a St. Louis jury awarded $495 million — $95 million compensatory plus $400 million punitive — against Abbott over Similac-linked NEC.
  • April 2026: a Cook County jury awarded $70 million against Abbott to four families whose infants developed NEC after Similac feedings.
  • October 2026: 844 NEC formula cases are pending in federal MDL 3026 before Judge Rebecca Pallmeyer in Illinois, per the Judicial Panel on Multidistrict Litigation.

What the $60 Million Verdict Actually Was

In March 2024, in the first NEC baby-formula trial ever held, a St. Clair County, Illinois jury unanimously sided with Jasmine Watson, whose premature son died of NEC after being fed Enfamil. The $60 million award was entirely compensatory, because Illinois wrongful-death law barred punitive damages in her case.

In June 2026, an Illinois appellate court reversed the judgment and remanded for a new trial. A bellwether trial is a test case chosen from a group of similar lawsuits; its result is not binding on the others, and appeals frequently reshape verdicts. The verdict proves a jury can find a manufacturer failed to warn about NEC — it is not a promised payout.

What These Lawsuits Actually Claim

NEC — necrotizing enterocolitis — is a severe gastrointestinal disease in which tissue in a premature infant's bowel becomes inflamed and begins to die; published reporting places mortality as high as 50 percent. The core allegation: Abbott (Similac) and Mead Johnson (Enfamil) knew or should have known cow's-milk-based formulas sharply raise the NEC risk for premature infants, yet marketed them as safe — even comparable to breast milk — without an adequate warning.

The federal cases sit in a multidistrict litigation (MDL), a federal procedure that consolidates similar lawsuits from before a single judge for coordinated pretrial proceedings. MDL 3026 was centralized in April 2022 before Judge Rebecca Pallmeyer in the Northern District of Illinois; hundreds of additional cases proceed in state courts.

Six Verdicts, Mixed Results

The trial record is genuinely mixed. Plaintiffs won the $60 million Watson verdict (2024, later remanded), the $495 million Gill verdict (2024), and the $70 million Cook County verdict (2026). Defendants won Whitfield (2024, later vacated) and Inman v. Mead Johnson, the first federal bellwether, in August 2026.

Bellwether trials show how different juries react to different facts; no headline verdict guarantees any other family's outcome.

In August 2026, Abbott agreed to pay approximately $670 million to resolve the Gill case and roughly 2,000 additional NEC claims, without admitting liability. The settlement does not cover Mead Johnson or Enfamil claims; Abbott has said roughly 1,700 lawsuits remain pending in state and federal courts.

Who Qualifies to File

Law firms screening NEC claims generally require four documented elements:

  • A premature birth — most strong claims involve infants born well before full term.
  • Feeding with cow's-milk-based formula (Similac or Enfamil) in a NICU.
  • A documented NEC diagnosis, including hospital and often operative or pathology records.
  • Filing within the applicable statute of limitations, which varies by state — there is no single national deadline.

Feeding logs naming the exact product are critical; proving the infant received the defendant's formula is a central battleground. Surviving children with lasting complications also qualify — the claim is about the injury, not only about deaths. Standards differ across mass torts (compare the hernia mesh lawsuits), so a NEC claim must stand on its own records.

How to File a NEC Formula Claim

Start with records: the complete NICU chart, feeding logs, operative and pathology reports, and any product packaging. Most families then consult a mass-tort firm experienced in failure-to-warn cases — review is free, and reputable firms work on contingency, typically 33 to 40 percent of any recovery, meaning no upfront fee and none if the case loses. Failure-to-warn claims follow a familiar structure across mass torts, from the paraquat lawsuits to these NEC cases.

If accepted, the claim is filed and transferred into MDL 3026 for discovery under the court's schedule. Cases run for years, and bellwether trials scheduled through 2026 shape settlement leverage for everyone else. For plain-language explainers on mass-tort cases, see the Problem Solved channel.

Fees, Deadlines, and the Settlement Reality

Contingency fees typically run 33 to 40 percent of a recovery plus deducted case costs — confirm the split in writing before signing. Statutes of limitation vary by state, and missing one ends a claim, so screen early. The same deadline pressure applies in other device litigations, including Exactech recall cases.

Compensation varies widely by case; most settlements are confidential, so no reliable public per-case figures exist. Verdicts are specific to their cases' facts and are frequently appealed — they are not a price list, and defendants contest causation vigorously, as the recent defense verdicts show.

Who Benefits From This — and Who Does Not

This guide serves families weighing an NEC formula claim — but the claim turns on specific records, and some families will find it does not fit their case.

Who benefits:

  • Parents of a premature infant diagnosed with NEC after cow’s-milk-based formula in a NICU. Compare the birth record, NICU feeding logs naming Similac or Enfamil, and the NEC diagnosis against the four documented elements in “Who Qualifies to File.”
  • Families of surviving children with lasting NEC complications. Note that the claim concerns the injury, not only deaths — short-bowel syndrome, repeated hospitalizations, and neurological injury are all part of the picture.
  • Families deciding whether filing is worth pursuing. Use the genuinely mixed trial record — plaintiff wins and defense wins — and the fact that cases run for years through MDL 3026 to set expectations before a free case review.

Who does not benefit:

  • Families whose infant was never fed a cow’s-milk-based formula, or never diagnosed with NEC. The lawsuits turn on both elements; without them there is no failure-to-warn claim of this kind.
  • Anyone looking for a promised payout. Verdicts are specific to their cases’ facts and frequently appealed — the $60 million Watson verdict was remanded for a new trial, and Abbott’s agreement of about $670 million covers Abbott claims only, not Mead Johnson or Enfamil.
  • Parents seeking urgent medical advice for a sick infant. This is legal information, not medical guidance; urgent questions belong to the treating NICU team.

Related reading: paraquat lawsuits.

FAQ

Can I file an NEC lawsuit if my baby survived NEC?

Yes. Surviving children with complications — short-bowel syndrome, repeated hospitalizations, neurological injury — can bring claims; the lawsuit is about the injury, not only deaths.

How long does a NEC baby formula lawsuit take?

Expect years: federal cases are folded into MDL 3026, where bellwether trials through 2026 shape settlement negotiations. State cases move on separate schedules, and appeals can add significant time.

Do I have to pay anything upfront to file?

No. Reputable mass-tort firms handle NEC cases on contingency — typically 33 to 40 percent of any recovery — with no upfront fee and none if the case loses. Confirm the fee split in writing before signing.

Who benefits most from this NEC lawsuit guide?

Parents of premature infants fed Similac or Enfamil in a NICU and later diagnosed with NEC — including families of surviving children with complications — because the guide maps their records against the four screening elements firms generally require.

Who is unlikely to benefit from an NEC formula claim?

Families whose infant was never fed a cow’s-milk-based formula or never diagnosed with NEC, since the lawsuits turn on both elements; and anyone expecting a guaranteed payout, because verdicts have gone both ways and the $60 million Watson verdict was remanded for a new trial.

How do I start checking whether my family qualifies?

Gather the premature birth record, the NICU feeding logs naming the exact product, and the NEC diagnosis with hospital and operative or pathology records, then compare them with the four elements in “Who Qualifies to File” — case review is free, and reputable firms work on contingency, typically 33 to 40 percent of any recovery, with no upfront fee.

This article is general information, not legal or financial advice.

Watch on YouTube

Problem Solved on YouTube